Sera Prognostics, Inc. (SERA)
2.03
-0.04
(-1.93%)
USD |
NASDAQ |
Oct 15, 16:00
2.07
+0.04
(+1.97%)
After-Hours: 20:00
Sera Prognostics Cash from Operations (TTM) : -27.68M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.68M |
| March 31, 2026 | -26.84M |
| December 31, 2025 | -25.62M |
| September 30, 2025 | -25.76M |
| June 30, 2025 | -26.28M |
| March 31, 2025 | -26.74M |
| December 31, 2024 | -14.19M |
| September 30, 2024 | -14.69M |
| June 30, 2024 | -15.29M |
| March 31, 2024 | -17.31M |
| December 31, 2023 | -27.19M |
| September 30, 2023 | -27.66M |
| Date | Value |
|---|---|
| June 30, 2023 | -28.84M |
| March 31, 2023 | -29.93M |
| December 31, 2022 | -34.61M |
| September 30, 2022 | -36.52M |
| June 30, 2022 | -37.04M |
| March 31, 2022 | -34.24M |
| December 31, 2021 | -31.64M |
| September 30, 2021 | -26.67M |
| June 30, 2021 | -21.30M |
| March 31, 2021 | -19.20M |
| December 31, 2020 | -16.87M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Myriad Genetics, Inc. | 7.70M |
| BioRestorative Therapies, Inc. | -11.82M |
| CareDx, Inc. | 93.66M |
| Natera, Inc. | 228.24M |
| Exagen, Inc. | -6.498M |